Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Heartflow, Inc. - Common Stock (NQ:HTFL)

33.64 +0.80 (+2.44%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jun 18, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Heartflow, Inc. - Common Stock

These stocks are moving in today's after hours session ↗
Via Chartmill
News headline image
Is HeartFlow Stock a Buy After an Institutional Investor Initiated a Position Worth $2.7 Million? ↗
HeartFlow delivers AI-powered, non-invasive cardiac diagnostics for hospitals and cardiology clinics using proprietary imaging technology. 
Via The Motley Fool
Topics Artificial Intelligence Regulatory Compliance
News headline image
Heartflow Q1 Earnings Call Highlights ↗
Heartflow (NASDAQ:HTFL) reported a sharply higher first-quarter revenue total and raised its full-year 2026 outlook, citing strength in its core FFRCT business, faster-than-expected adoption of its... 
Via MarketBeat
Topics Artificial Intelligence Earnings
Heartflow Inc (NASDAQ:HTFL) Beats Q1 Estimates and Hikes Full-Year Outlook, But Stock Slips After Hours ↗
Via Chartmill
Heartflow Inc (NASDAQ:HTFL) Reports Strong Q4 Revenue Beat and Improved Margins Despite After-Hours Share Decline ↗
Via Chartmill
News headline image
Earnings Scheduled For November 12, 2025 ↗
 
Via Benzinga
News headline image
Wall Street Waits for the SpaceX IPO, These 2 Under-the-Radar IPOs Could Already Be Making You Money ↗
Heartflow and Neptune Insurance deserve a closer look. 
Via The Motley Fool
Topics Artificial Intelligence Initial Public Offering
News headline image
Stanford Trustees Exited HeartFlow Stock for $8.5 Million. Here's What That Means for Investors. ↗
HeartFlow provides AI-driven tools for non-invasive heart diagnostics, serving hospitals and clinics with advanced cardiovascular insights. 
Via The Motley Fool
Topics Artificial Intelligence
News headline image
What Investors Should Know About One HeartFlow Insider's $2 Million Stock Sale ↗
HeartFlow delivers AI-powered cardiac diagnostics to hospitals worldwide; a key insider recently trimmed their stake, SEC filings show. 
Via The Motley Fool
Topics Artificial Intelligence Regulatory Compliance
News headline image
Is HeartFlow Stock a Buy After Capricorn Investment Group Bought 1.7 Million Shares? ↗
HeartFlow delivers AI-powered, non-invasive cardiac diagnostics to healthcare providers seeking advanced imaging and decision support tools. 
Via The Motley Fool
News headline image
EXCLUSIVE: Aclarion CEO Looks To Bigger AI MedTech’s Playbook To Reverse Fortunes ↗
CEO Brent Ness noted a broad global market, with approximately 266 million people affected by chronic low back pain. 
Via Stocktwits
Topics Artificial Intelligence
News headline image
Is Recent IPO Stock Heartflow a Buy After a Director Scooped Up Shares Worth Over $1 Million? ↗
AI-powered cardiac diagnostics firm HeartFlow reported a recent insider buy, as disclosed in the latest SEC filing. 
Via The Motley Fool
Topics Artificial Intelligence Initial Public Offering Regulatory Compliance
News headline image
Why AI Stock HeartFlow Triumphed on Thursday ↗
A key FDA-cleared analysis tool earned professional accolades for its utility. 
Via The Motley Fool
Topics Artificial Intelligence
News headline image
This Family Office Acquired $148 Million of Karman Stock as Shares Tripled Since February IPO ↗
One family office fund just made Karman its biggest reported equity bet—here’s what long-term investors should take from the move. 
Via The Motley Fool
Topics Regulatory Compliance Supply Chain
News headline image
Billionaire Family Office Acquires $65 Million of HeartFlow as Stock Jumps 70% From IPO ↗
A billionaire family office has made a big bet on a newly public AI-driven heart diagnostics company—here’s what long-term investors should take from the move. 
Via The Motley Fool
Topics Artificial Intelligence Initial Public Offering Regulatory Compliance
News headline image
Investment Powerhouse Backs Biotech Stock to the Tune of $419 Million ↗
Bain Capital added more than 12.4 million shares of HeartFlow stock in the thrid quarter 
Via The Motley Fool
Topics Artificial Intelligence Regulatory Compliance
News headline image
Institutional Titan Hits the Jackpot: Biotech Stock Surges by 116% on Buyout Offer ↗
Bain Capital's bet on Cidara Therapeutics stocks has paid off in a big way 
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Biotech Stock Gets Booted in Latest Fund Update ↗
Bain Capital sold its entire stake in Nuvalent stock during the third quarter. 
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Portfolio Adjustment: Institutional Heavyweight Exits Biotech Stock ↗
Bain Capital completely exited its position in Disc Medicine stock during the third quarter 
Via The Motley Fool
News headline image
Why Bain Capital Is Selling Shares of This Biotech Stock Now ↗
Bain Capital sold $20 million worth of Pharvaris stock during the third quarter. 
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Where Innovation Meets the Heart: Stanford’s New Position in HeartFlow ↗
Stanford just bought into HeartFlow. Here is what caught Stanford’s eye and what investors need to know about HeartFlow’s early trajectory and long-term potential. 
Via The Motley Fool
Topics Artificial Intelligence ETFs
News headline image
Heartflow Inc (NASDAQ:HTFL) Posts Mixed Q3 2025 Results with Strong Revenue Beat and Upbeat Guidance ↗
Heartflow Q3 2025 earnings show strong revenue growth, beating estimates, and confident full-year guidance. 
Via Chartmill
News headline image
Alpha Buying: 118 Years of Finding World-Changing Stocks ↗
 
Via Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.